Written by Lorraine Mullaney || 22nd September 2020 || Business briefing || Consumers | FDA | Retail | Geographies: North America United States US vape stores are diversifying into CBD and oral nicotine, while others fear being blamed by customers for reduced choice as FDA premarket tobacco product regulations cause products to disappear from the shelves ... Are you already a subscriber? login here Login Username or Email Password Remember me Forget? | Register Username or Email Back to Login | Register Enjoy free subscription accessGet access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors. I want a free trial Benefits of subscription plans:Stay informed of any legal and market change in the sector that impacts your organizationMaximise resources by getting market and legal data analysis daily in one placeMake smart decisions by understanding how the regulatory and market landscape evolvesAnticipate risks in your decisions by monitoring regulatory changes that impact your organizationNeed help?Contact a sales representative right now and don’t waitErik Galavis +34 654 320 547 Email Erik Related contents Vape stores and PMTA – what’s coming next? ECigIntelligence US survey 2020 Consumer survey report: changes in vape consumer preferences in the US As PMTA deadline passes, is it the point of no return for vaping in the US?